US Associates in Research LLC

1. Evofem Biosciences, Inc. $266,377 28 payments
2. Regeneron Pharmaceuticals, Inc. $107,706 10 payments
3. Sage Therapeutics, Inc. $87,119 7 payments

1. Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) $208,105 19 payments
2. A Master Protocol of Randomized, Double-Blind, Placebo-Controlled, Phase 2 Studies of siRNA Gene Silencing for the Treatment of Non- Alcoholic Steatohepatitis (NASH) in Participants With Genetic Risk Factors $93,334 6 payments
3. Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection $58,272 9 payments
4. A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor $41,060 2 payments
5. Study to Evaluate SAGE-324 in Participants With Essential Tremors $28,339 2 payments
6. Study to Evaluate Sage-324 in Participants With Essential Tremors $17,720 3 payments
7. A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors $14,372 4 payments

1. Professional salary support $215,527 24 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.